Viewing nowGlimin Tablet (Glimiperide)
Glimepiride 2mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

MFDS item code 200301601 · Notified 2003.12.03 · Insurance code 648100290
Improvement of blood glucose control in type 2 diabetes
This medication assists in dietary and exercise therapy to enhance blood sugar control in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is insufficient, it may be used in combination with oral hypoglycemic agents or insulin. Specifically, it is used in combination with metformin when the effects of sulfonylureas or metformin monotherapy are inadequate. This multifaceted treatment effectively manages blood sugar to aid in diabetes management.
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetic control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this medicine There is no precise dose equivalence between this medicine and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be considered. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be administered to patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients who have had allergic reactions to this medication or its components, or to sulfonylureas should also refrain from use. This medication is not used in patients with severe liver or kidney dysfunction, and in such cases, transitioning to insulin therapy is recommended. Pregnant or potentially pregnant women, as well as nursing mothers, should not take this medicine. Patients with severe infections, or those undergoing surgery or with severe injuries may require insulin therapy, so caution is needed when using this medication. In cases where food absorption is impaired due to diarrhea or vomiting, there is a risk of hypoglycemia, so caution must be exercised. During the first week of taking this medication, the risk of hypoglycemia is high, so blood sugar levels should be closely monitored. Special care should be taken in elderly patients, those with poor nutritional status or skipping meals, or those with an imbalance of exercise and carbohydrate intake. Patients who frequently consume alcohol or have impaired kidney and liver function may also have an increased risk of hypoglycemia. Additionally, having other endocrine disorders or taking certain medications could also increase the risk of hypoglycemia. It is recommended to consult with a doctor or pharmacist regarding dosage or administration when there are such risk factors. The most common side effect of this medication is hypoglycemia, which may present symptoms such as headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, or decreased consciousness. Hypoglycemia should be treated immediately by taking sugar, and in severe cases, emergency treatment may be required. Furthermore, initial blood sugar changes may lead to blurred vision, gastrointestinal symptoms, liver function abnormalities, blood disorders, or allergic reactions, so any unusual symptoms should be reported to medical personnel immediately. Rarely, serious allergic reactions or liver failure may occur, necessitating caution. When taking this medication, regular meals, exercise, and weight management are important, and blood sugar control should be continuously monitored. Patients and their families should be thoroughly informed about the symptoms and risk factors of hypoglycemia, and preparations should be made to consume sugar immediately upon hypoglycemic episodes. Extra careful monitoring is needed, especially at the beginning of treatment or when changing dosages. Stressful situations or surgery and infections may complicate blood sugar management, sometimes necessitating a switch to insulin therapy. This medication has many interactions with other drugs, so it's essential to inform a doctor or pharmacist if taking other medications or stopping any medications. Special caution is needed when taken alongside medications that lower or raise blood sugar levels, as this can affect blood sugar control. Additionally, since this medication is metabolized in the liver, caution is advised when used with drugs that affect liver metabolism. Pregnant or nursing mothers should not take this medication, as it may harm the fetus or newborn. If planning a pregnancy, consultation with a doctor to switch to insulin therapy is advisable. This medication has not been proven safe and effective for children under 18 years of age, so it should not be used in this population. In elderly patients, renal function may be reduced, requiring careful adjustment of dosage. In cases of overdose, severe hypoglycemia may occur, so immediate emergency treatment must be sought at a medical facility, and treatments such as inducing vomiting, blocking drug absorption, or intravenous glucose may be necessary. This medication should be stored out of reach of children and kept in its original container to prevent misuse and deterioration of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container to protect it from air and moisture. Additionally, it is recommended to store it at room temperature, away from direct sunlight, between 1 and 30 degrees Celsius.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.